Delta opioid receptors are essential to the antiallodynic action of Β2-mimetics in a model of neuropathic pain-Reference-Cited by-同舟云学术

Delta opioid receptors are essential to the antiallodynic action of Β2-mimetics in a model of neuropathic pain

Published:2020-01 Issue: Volume:16 Page:174480692091293
ISSN:1744-8069
Container-title:Molecular Pain
language:en
Short-container-title:Mol Pain

Author:

Kremer Mélanie¹^ORCID,Megat Salim¹,Bohren Yohann¹,Wurtz Xavier¹,Nexon Laurent¹,Ceredig Rhian Alice¹,Doridot Stéphane²,Massotte Dominique¹,Salvat Eric¹³,Yalcin Ipek¹,Barrot Michel¹

Affiliation:

1. Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France

2. Centre National de la Recherche Scientifique, Université de Strasbourg, Chronobiotron, Strasbourg, France

3. Hôpitaux Universitaires de Strasbourg, Centre d’Evaluation et de Traitement de la Douleur, Strasbourg, France

Funder

Fédéeh Hewlett Packard

Fondation d’Entreprise Banque Populaire

Agence Nationale de la Recherche

University of Strasbourg

Centre National de la Recherche Scientifique

Publisher

SAGE Publications

Subject

Anesthesiology and Pain Medicine,Cellular and Molecular Neuroscience,Molecular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1744806920912931

Reference58 articles.

1. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

2. Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

3. Antidepressants for neuropathic pain: a Cochrane review

4. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights

5. Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term application of adrenergic agonists modulates nociceptive ion channels;Neuroscience Letters;2024-02

2. Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons;Pharmacology & Therapeutics;2023-11

3. Re-Purposing FDA-Approved Drugs for Opioid Use Disorder;Substance Use & Misuse;2023-08-16

4. Activation of β2-Adrenergic Receptors in Microglia Alleviates Neuropathic Hypersensitivity in Mice;Cells;2023-01-11

5. Activation of β2-adrenergic receptors in microglia alleviates neuropathic hypersensitivity in mice;2022-12-18